Used as a key intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of antifungal and anticancer agents. Its structure allows for selective modification in drug design, enhancing metabolic stability and bioavailability. Commonly employed in the preparation of active pharmaceutical ingredients (APIs) where fluorine substitution improves target binding and pharmacokinetic properties. Also utilized in the production of specialty polymers and agrochemicals requiring fluorinated building blocks.